|
|
|||
| |||||||||||||||||||||||||||||||||||||||
-1,3-galactosyltransferase target of humoral rejection is particularly promising.1 Although the possibility of introducing new infections from source animals into humans has been a concern,2 such transmission has apparently not occurred in xenotransplantations to date.3 Nevertheless, this theoretical risk mandates caution in clinical xenotransplantation. Consequently, considerable effort has been made in several countries to develop guidelines for the husbandry of source animals and for the monitoring of
HOME | SUBSCRIBE | SEARCH | CURRENT ISSUE | PAST ISSUES | COLLECTIONS | PRIVACY | TERMS OF USE | HELP | beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2009 Massachusetts Medical Society. All rights reserved. |